Results
|
401.
|
|
|
402.
|
|
|
403.
|
|
|
404.
|
|
|
405.
|
|
|
406.
|
|
|
407.
|
|
|
408.
|
|
|
409.
|
|
|
410.
|
|
|
411.
|
|
|
412.
|
|
|
413.
|
|
|
414.
|
|
|
415.
|
The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide. [electronic resource] by
- Stiborová, Marie
- Sejbal, Jan
- Borek-Dohalská, Lucie
- Aimová, Dagmar
- Poljaková, Jitka
- Forsterová, Kristina
- Rupertová, Martina
- Wiesner, Jirí
- Hudecek, Jirí
- Wiessler, Manfred
- Frei, Eva
Producer: 20050224
In:
Cancer research vol. 64
Availability: No items available.
|
|
416.
|
|
|
417.
|
|
|
418.
|
Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells. [electronic resource] by
- Hrabeta, Jan
- Groh, Tomas
- Khalil, Mohamed Ashraf
- Poljakova, Jitka
- Adam, Vojtech
- Kizek, Rene
- Uhlik, Jiri
- Doktorova, Helena
- Cerna, Tereza
- Frei, Eva
- Stiborova, Marie
- Eckschlager, Tomas
Producer: 20160517
In:
International journal of oncology vol. 47
Availability: No items available.
|
|
419.
|
|
|
420.
|
|